882855-68-7 Usage
Description
(1S,3R,5S)-3-[(benzyloxy)carbonyl]amino-5-hydroxycyclohexane-1-carboxylic acid is a complex organic compound with a unique molecular structure. It features a cyclohexane ring with specific stereochemistry at the 1, 3, and 5 positions, and a benzyloxycarbonyl group attached to the 3-position. (1S,3R,5S)-3-[(benzyloxy)carbonyl]amino-5-hydroxycyclohexane-1-carboxylic acid has potential applications in various fields due to its structural properties and functional groups.
Uses
Used in Pharmaceutical Industry:
(1S,3R,5S)-3-[(benzyloxy)carbonyl]amino-5-hydroxycyclohexane-1-carboxylic acid is used as a key intermediate in the synthesis of fluorinated conformationally restricted analogues of GABA (gamma-aminobutyric acid). These analogues have potential as inhibitors of GABA aminotransferase, an enzyme involved in the metabolism of GABA. By inhibiting this enzyme, these analogues could modulate GABA levels in the brain, which may have therapeutic applications in treating neurological disorders associated with imbalances in GABAergic signaling.
Additionally, the benzyloxycarbonyl group in this compound can be used as a protecting group in organic synthesis, allowing for selective reactions to occur at other sites on the molecule. This feature makes (1S,3R,5S)-3-[(benzyloxy)carbonyl]amino-5-hydroxycyclohexane-1-carboxylic acid a versatile building block for the development of new pharmaceutical agents and other bioactive compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 882855-68-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,2,8,5 and 5 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 882855-68:
(8*8)+(7*8)+(6*2)+(5*8)+(4*5)+(3*5)+(2*6)+(1*8)=227
227 % 10 = 7
So 882855-68-7 is a valid CAS Registry Number.
882855-68-7Relevant articles and documents
Pyrimidine amine compound, and preparation method and application thereof
-
, (2020/07/02)
The invention discloses a polycyclic compound, and a preparation method and an application thereof. The invention provides the polycyclic compound represented by formula I, or a pharmaceutically acceptable salt thereof. The compound has a relatively good inhibition effect on CDK7.
